The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment.

Front Immunol · 2023 · PMC10244756 · PMID 37292204

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Hence, an increasing trend is observed to leverage nanotherapy as an approach to improve the immune response of tumors by targeting the TME in head and neck squamous cell carcinoma (HNSCC), as summarized in Table 2 ( 69 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.